DK-INJECT ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.3% 1.3% 1.3% 1.3% 1.3%  
Bankruptcy risk  1.6% 1.4% 1.3% 1.8% 1.3%  
Credit score (0-100)  76 78 79 71 79  
Credit rating  A A A A A  
Credit limit (kDKK)  100.5 249.6 635.3 25.0 620.1  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  5,585 -227 -240 -99.5 -91.0  
EBITDA  4,787 -448 -399 -257 -270  
EBIT  4,576 -642 -502 -594 -578  
Pre-tax profit (PTP)  6,997.8 1,073.3 2,204.3 -2,200.9 2,368.6  
Net earnings  5,458.6 836.6 1,717.5 -2,188.2 2,234.7  
Pre-tax profit without non-rec. items  6,998 1,073 2,204 -2,201 2,369  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  310 5,955 11,258 13,754 13,446  
Shareholders equity total  35,545 36,282 37,899 35,611 37,746  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  35,848 36,557 38,403 35,963 38,097  

Net Debt  -34,834 -27,133 -25,498 -21,789 -24,016  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  5,585 -227 -240 -99.5 -91.0  
Gross profit growth  -74.7% 0.0% -5.7% 58.5% 8.5%  
Employees  0 0 0 0 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  35,848 36,557 38,403 35,963 38,097  
Balance sheet change%  0.8% 2.0% 5.1% -6.4% 5.9%  
Added value  4,786.6 -448.2 -398.7 -490.8 -269.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -341 5,450 5,201 2,159 -617  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  81.9% 283.1% 209.2% 597.2% 635.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  19.6% 3.0% 5.9% 0.4% 6.6%  
ROI %  20.2% 3.0% 6.0% 0.4% 6.6%  
ROE %  15.9% 2.3% 4.6% -6.0% 6.1%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  99.4% 99.2% 98.7% 99.0% 99.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -727.7% 6,053.9% 6,394.7% 8,469.4% 8,901.2%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  222.7 125.1 55.1 63.0 70.0  
Current Ratio  151.4 125.1 55.1 63.0 70.0  
Cash and cash equivalent  34,834.1 27,133.0 25,498.5 21,789.4 24,015.6  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  12,153.4 7,318.4 4,474.2 3,264.8 5,551.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 -270  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 -270  
EBIT / employee  0 0 0 0 -578  
Net earnings / employee  0 0 0 0 2,235